Cargando…
Multiple myeloma/hypercalcemia
Multiple myeloma, a cancer of plasma cells, is associated with excessive tumor-induced, osteoclast-mediated bone destruction. Hypercalcemia remains the most frequent metabolic complication of myeloma in patients, and excessive osteolysis plays a major contributory role in its pathogenesis. The clini...
Autor principal: | Oyajobi, Babatunde O |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924519/ https://www.ncbi.nlm.nih.gov/pubmed/17634143 http://dx.doi.org/10.1186/ar2168 |
Ejemplares similares
-
Acute Pancreatitis in a Case of Multiple Myeloma with Hypercalcemia
por: Lee, Kyoo Hyung, et al.
Publicado: (1989) -
Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells
por: De Veirman, Kim, et al.
Publicado: (2015) -
Synthesis of a Bone-Targeted Bortezomib with In Vivo Anti-Myeloma Effects in Mice
por: Wang, Hua, et al.
Publicado: (2018) -
Hypercalcemia, Renal Failure, and Skull Lytic Lesions: Follicular Lymphoma Masquerading as Multiple Myeloma
por: Alhaj Moustafa, Muhamad, et al.
Publicado: (2013) -
A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in mice
por: Sharma, Ramaswamy, et al.
Publicado: (2015)